Stock HTGC HERCULES CAPITAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Hercules Capital, Inc.

Equities

HTGC

US4270965084

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-02 pm EDT 		Pre-market 06:37:16 pm
19.3 USD 0.00% Intraday chart for Hercules Capital, Inc. 19.28 -0.08%
Apr. 30 Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment MT
Apr. 03 KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hercules Capital: Q1 Earnings Snapshot
AQ
Hercules Capital Reports First Quarter 2024 Financial Results
BU
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
BU
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024
CI
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment
MT
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
BU
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
BU
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.
CI
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
BU
Bluebird bio to Restate Financial Statements; Shares Fall
MT
JMP Securities Adjusts Hercules Capital Price Target to $19 From $18, Maintains Market Outperform Rating
MT
Hercules Capital Receives Confirmed BBB Investment Grade Rating with Revised Outlook to Positive from Morningstar DBRS
BU
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon
MT
Sector Update: Health Care
MT
Bluebird bio Secures $175 Million Term Loan Facility
MT
REVELEER SECURES $65 MILLION IN FINANCING TO DRIVE STRATEGIC EXPANSION AND ENHANCE PRODUCT OFFERINGS
AQ
Ex-dividend day
FA
Health Data Vision, Inc. announced that it has received $65 million in funding from Hercules Capital, Inc.
CI
Hercules Capital Announces Upcoming Event for the Financial Community
BU
Piper Sandler Raises Price Target on Hercules Capital to $20 From $18.50, Maintains Overweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HTGC Stock
  4. News Hercules Capital, Inc.